Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ABBVNYSE:IBMNYSE:O On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABBVAbbVie$173.80-3.4%$200.47$153.58▼$218.66$307.44B0.555.93 million shs13.96 million shsIBMInternational Business Machines$229.18-2.6%$249.72$162.62▼$266.45$212.51B0.674.21 million shs5.65 million shsORealty Income$54.09+0.2%$55.85$50.65▼$64.88$48.24B0.795.30 million shs7.98 million shsThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABBVAbbVie-3.34%-13.67%-18.68%-0.79%+2.84%IBMInternational Business Machines-2.72%-5.87%-7.97%+4.46%+23.26%ORealty Income+0.07%-5.11%-4.66%+4.56%+3.74%Remove AdsCompare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationABBVAbbVie4.8333 of 5 stars3.45.03.33.93.32.51.3IBMInternational Business Machines4.1123 of 5 stars2.22.03.33.53.31.71.9ORealty Income3.965 of 5 stars3.14.02.51.72.71.70.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceABBVAbbVie 2.88Moderate Buy$210.7121.24% UpsideIBMInternational Business Machines 2.41Hold$231.130.85% UpsideORealty Income 2.21Hold$62.4215.41% UpsideCurrent Analyst Ratings BreakdownLatest ABBV, IBM, and O Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/9/2025ABBVAbbVieMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$239.00 ➝ $241.004/8/2025ABBVAbbVieThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingStrong-Buy ➝ Neutral$194.004/3/2025ORealty IncomeMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$54.00 ➝ $59.003/31/2025IBMInternational Business MachinesJefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$270.00 ➝ $265.003/17/2025ABBVAbbVieErste Group BankSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy3/17/2025IBMInternational Business MachinesErste Group BankSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Strong-Buy3/5/2025ABBVAbbVieWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$210.00 ➝ $240.003/4/2025ABBVAbbVieBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$200.00 ➝ $223.003/4/2025ORealty IncomeBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$56.00 ➝ $59.002/28/2025ORealty IncomeScotiabankSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetSector Perform ➝ Sector Perform$59.00 ➝ $57.002/26/2025ORealty IncomeRoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$62.00 ➝ $60.00(Data available from 4/11/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookABBVAbbVie$56.33B5.46$12.85 per share13.53$1.90 per share91.47IBMInternational Business Machines$62.75B3.39$13.43 per share17.06$29.62 per share7.74ORealty Income$5.27B9.15$3.63 per share14.90$45.73 per share1.18Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateABBVAbbVie$4.28B$2.4072.4212.431.627.59%296.28%12.65%4/25/2025 (Estimated)IBMInternational Business Machines$6.02B$6.4135.7519.765.819.60%38.99%7.14%4/23/2025 (Estimated)ORealty Income$872.31M$0.9851.5112.522.1017.57%2.35%1.34%5/5/2025 (Estimated)Latest ABBV, IBM, and O EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/5/2025Q1 2025ORealty Income$1.06N/AN/AN/A$1.28 billionN/A4/25/2025Q1 2025ABBVAbbVie$2.51N/AN/AN/A$12.91 billionN/A4/23/2025Q1 2025IBMInternational Business Machines$1.43N/AN/AN/A$14.41 billionN/A2/24/2025Q4 2024ORealty Income$1.06$1.05-$0.01$1.05$1.28 billion$1.34 billion1/31/2025Q4 2024ABBVAbbVie$2.98$2.16-$0.82-$0.02$14.81 billionN/A1/29/2025Q4 2024IBMInternational Business Machines$3.77$3.92+$0.15$3.10$17.60 billionN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthABBVAbbVie$6.563.77%+6.04%273.33%53 YearsIBMInternational Business Machines$6.682.91%+0.61%104.21%29 YearsORealty Income$3.225.95%-3.64%328.57%N/ALatest ABBV, IBM, and O DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date2/13/2025ABBVAbbViequarterly$1.643.4%4/15/20254/15/20255/15/20254/8/2025ORealty Incomemay 25$0.26856%5/1/20255/1/20255/15/20253/12/2025ORealty Incomeapr 25$0.26855.7%4/1/20254/1/20254/15/20252/19/2025ORealty Incomemar 25$0.26805.7%3/3/20253/3/20253/14/20251/28/2025IBMInternational Business MachinesQuarterly$1.672.92%2/10/20252/10/20253/10/20251/14/2025ORealty Incomefeb 25$0.26405.9%2/3/20252/3/20252/14/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioABBVAbbVie17.940.660.55IBMInternational Business Machines1.821.041.00ORealty Income0.681.401.40Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipABBVAbbVie70.23%IBMInternational Business Machines58.96%ORealty Income70.81%Insider OwnershipCompanyInsider OwnershipABBVAbbVie0.25%IBMInternational Business Machines0.18%ORealty Income0.10%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableABBVAbbVie50,0001.77 billion1.76 billionOptionableIBMInternational Business Machines311,300927.26 million924.00 millionOptionableORealty Income400891.77 million874.34 millionOptionableABBV, IBM, and O HeadlinesRecent News About These CompaniesRealty Income (NYSE:O) Trading 0.1% Higher After Dividend AnnouncementApril 11 at 1:17 AM | americanbankingnews.comRealty Income: Sleep Well At Night During Uncertain TimesApril 11 at 12:10 AM | seekingalpha.comRealty Income Announces First Quarter 2025 Earnings Release DateApril 10 at 4:13 PM | prnewswire.comRealty Income Becoming Attractive Again: $50/Share And I'm InApril 10 at 1:21 PM | seekingalpha.comRealty Income Becoming Attractive Again: $50/Share And I'm InApril 10 at 1:15 PM | seekingalpha.comRealty Income (NYSE:O) Trading Up 0.1% After Dividend AnnouncementApril 10 at 11:25 AM | marketbeat.comAPG Asset Management US Inc. Trims Stock Position in Realty Income Co. (NYSE:O)April 10 at 7:11 AM | marketbeat.comRealty Income Corporation (O): Among the High Growth Dividend Paying Stocks to Invest inApril 9 at 6:23 PM | insidermonkey.com3 Dividend Stocks to Double Up on Right NowApril 9 at 6:05 PM | fool.comRealty Income Co. (NYSE:O) Announces May 25 Dividend of $0.27April 9 at 5:19 PM | marketbeat.comRealty Income (NYSE:O) Stock Price Up 1.8% - Here's What HappenedApril 9 at 2:58 PM | marketbeat.comWant $1,000 in Annual Dividends? Invest $17,000 in These 3 StocksApril 9 at 5:12 AM | fool.comWant $1,000 in Annual Dividends? Invest $17,000 in These 3 StocksApril 9 at 5:12 AM | fool.com3 Top Dividend Stocks to Buy and Hold for the Next 20 YearsApril 9 at 3:21 AM | fool.comRealty Income Corp. (O) Stock Moves -1.28%: What You Should KnowApril 8 at 11:52 PM | msn.comThe Largest Real Estate Companies by Market Cap in April 2025April 8 at 11:52 PM | fool.comRealty Income (NYSE:O) Shares Down 3.1% - Should You Sell?April 8 at 10:49 PM | marketbeat.comRealty Income Announces 658th Consecutive Common Stock Monthly DividendApril 8 at 4:13 PM | prnewswire.comSharp Pullback - Start Building Your Income Portfolio: Realty IncomeApril 8 at 8:11 AM | seekingalpha.comSharp Pullback - Start Building Your Income Portfolio: Realty IncomeApril 8 at 7:35 AM | seekingalpha.comStock Market Sell-Off: 2 No-Brainer Stocks to Buy Right NowApril 8 at 7:07 AM | fool.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesAbbVie Stock Boosts Portfolios With Entry Into Weight Loss MarketBy Chris Markoch | March 23, 2025View AbbVie Stock Boosts Portfolios With Entry Into Weight Loss MarketThese 4 Stocks Offer High Upside in the AI Data Center BoomBy Sarah Horvath | March 28, 2025View These 4 Stocks Offer High Upside in the AI Data Center BoomIntel's Strategy to Win the Next AI FrontierBy Jeffrey Neal Johnson | March 27, 2025View Intel's Strategy to Win the Next AI FrontierAluminum Tariff Woes: Between 2 Stocks, 1 Shines BrighterBy Chris Markoch | March 20, 2025View Aluminum Tariff Woes: Between 2 Stocks, 1 Shines BrighterCintas Ends UniFirst Talks—What’s Next for UNF Stock?By Thomas Hughes | April 5, 2025View Cintas Ends UniFirst Talks—What’s Next for UNF Stock?ABBV, IBM, and O Company DescriptionsAbbVie NYSE:ABBV$173.80 -6.04 (-3.36%) Closing price 04/10/2025 03:59 PM EasternExtended Trading$174.20 +0.40 (+0.23%) As of 04/10/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.International Business Machines NYSE:IBM$229.18 -6.13 (-2.60%) Closing price 04/10/2025 03:59 PM EasternExtended Trading$227.24 -1.94 (-0.84%) As of 04/10/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.International Business Machines Corporation, together with its subsidiaries, provides integrated solutions and services worldwide. The company operates through Software, Consulting, Infrastructure, and Financing segments. The Software segment offers a hybrid cloud and AI platforms that allows clients to realize their digital and AI transformations across the applications, data, and environments in which they operate. The Consulting segment focuses on skills integration for strategy, experience, technology, and operations by domain and industry. The Infrastructure segment provides on-premises and cloud based server, and storage solutions, as well as life-cycle services for hybrid cloud infrastructure deployment. The Financing segment offers client and commercial financing, facilitates IBM clients' acquisition of hardware, software, and services. The company has a strategic partnership to various companies including hyperscalers, service providers, global system integrators, and software and hardware vendors that includes Adobe, Amazon Web services, Microsoft, Oracle, Salesforce, Samsung Electronics and SAP, and others. The company was formerly known as Computing-Tabulating-Recording Co. International Business Machines Corporation was incorporated in 1911 and is headquartered in Armonk, New York.Realty Income NYSE:O$54.09 +0.11 (+0.20%) Closing price 04/10/2025 03:59 PM EasternExtended Trading$54.10 +0.01 (+0.02%) As of 04/10/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Realty Income, The Monthly Dividend Company, is an S&P 500 company and member of the S&P 500 Dividend Aristocrats index. We invest in people and places to deliver dependable monthly dividends that increase over time. The company is structured as a real estate investment trust ("REIT"), and its monthly dividends are supported by the cash flow from over 15,450 real estate properties (including properties acquired in the Spirit merger in January 2024) primarily owned under long-term net lease agreements with commercial clients. To date, the company has declared 644 consecutive monthly dividends on its shares of common stock throughout its 55-year operating history and increased the dividend 123 times since Realty Income's public listing in 1994 (NYSE: O). More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Broadcom's Big Outperformance Shows Strength Amid Tariff Decline Delta, Walmart Cut Profit Targets: Could Start Domino Effect Joby Aviation: Operational Momentum vs. Market Sentiment Carvana: Can Turnaround Strength Outdrive Market Headwinds? Is Alphabet a Generational Buying Opportunity at These Levels? Meta Seeks Trump's Help in FTC Trial: The Implications Are Huge Is Microsoft Stock Too Cheap to Ignore After Its Latest Drop? Harley-Davidson Tops Watchlists: Value Trap or Turnaround Play? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
